Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2019-05-09. The firm has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The firm conducts business primarily in the United States, China, Europe and other regions.
Follow-Up Questions
VIVA Biotech Holdings 的 CEO 是誰？
Mr. Chen Cheney Mao 是 VIVA Biotech Holdings 的 Executive Chairman of the Board，自 2018 加入公司。
VBIZF 股票的價格表現如何？
VBIZF 的當前價格為 $0.31，在上個交易日 decreased 了 0%。
VIVA Biotech Holdings 的主要業務主題或行業是什麼？
VIVA Biotech Holdings 屬於 Life Sciences Tools & Services 行業，該板塊是 Health Care
